Technologyai
Science Corporation Implants Vision Chip in Stargardt Patient
Science Corporation, led by former Neuralink executive Max Hodak, has successfully implanted its PRIMA vision-restoring chip into the first patient suffering from Stargardt disease. The procedure took place in May at the Sydney Eye Hospital in Australia as part of an ongoing clinical trial. Stargardt disease is an inherited genetic condition that causes progressive central vision loss by destroying light-sensing cells in the retina. The innovative PRIMA implant works in tandem with specialized camera-equipped glasses to bypass damaged tissue and stimulate the optic nerve.